Source: Idaho Champion.
  • Idaho Champion (ITKO) has closed its oversubscribed private placement for gross proceeds of $1,116,787
  • Under the final tranche, the company issued 3,728,600 Québec FT shares and 1,866,667 FT shares for gross proceeds of $373,002
  • The gross proceeds from the issuance of the FT shares and Québec FT shares will be used for Canadian exploration expenses
  • Idaho Champion is an exploration company focused on cobalt and lithium
  • Idaho Champion Gold Mines Canada Inc. opened trading at $0.06 per share

Idaho Champion (ITKO) has closed its previously announced, oversubscribed private placement for gross proceeds of $1,116,787.

Under the final tranche, the company issued 3,728,600 Québec FT shares and 1,866,667 FT shares for gross proceeds of $373,002.

The gross proceeds from the FT shares and Québec FT shares will be used for Canadian exploration expenses.

All securities issued will be subject to a statutory four-month hold period.

Idaho Champion is a discovery-focused exploration company advancing its cobalt properties located in Idaho and lithium properties in Quebec.

Idaho Champion Gold Mines Canada Inc. (ITKO) opened trading at C$0.06.


More From The Market Online

@ the Bell: TSX sees first positive day in a week

Canadian stock markets moved up on Wednesday as investors await fresh cues about timing of this year’s interest rate cuts
TC Energy - Shot from the NGTL pipeline system.

TC Energy’s latest fuel spill sparks wildfire

The NGTL natural gas pipeline, owned by TC Energy, ruptured and caused a wildfire 40 kilometres northwest of Edson, Alberta, Tuesday morning.
PyroGenesis - PyroGenesis' STP torch for refrigerant destruction, hydrocracking and heating.

PyroGenesis to help global mining leader lower emissions

PyroGenesis Canada (TSX:PYR) signs a contract with a global mining supplier to apply its electric plasma torches towards emissions reduction.

Canadian biotech stock investigates potential weight loss drugs

FSD Pharma Inc. (CSE:HUGE) is expanding its pipeline into metabolic and related disorders including weight loss and liver health.